These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9014421)

  • 1. [The use of magnetic resonance imaging (MRI) and single photon emission computing tomography (SPECT) for the differential diagnosis of Parkinson's disease and other neurodegenerative disorders presenting as parkinsonism].
    Kohira I
    Nihon Rinsho; 1997 Jan; 55(1):39-42. PubMed ID: 9014421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
    Savoiardo M
    Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET and SPECT functional imaging in Parkinson's disease.
    Antonini A; DeNotaris R
    Sleep Med; 2004 Mar; 5(2):201-6. PubMed ID: 15033144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's disease and other basal ganglia disorders".
    Oertel WH; Trenkwalder C; Gasser T; Schwarz J; Bucher SF; Eichhorn T; Pogarell O; Künig G; Arnold G; Bandmann O
    J Neural Transm Suppl; 1995; 46():325-37. PubMed ID: 8821069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
    Okada J; Peppard R; Calne DB
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ["Red flags": when to be alerted and how to explore?].
    Tison F
    Rev Neurol (Paris); 2010 Oct; 166(10):775-8. PubMed ID: 20817230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphological magnetic resonance imaging: its value for the diagnosis of neurodegenerative diseases].
    Hahn U; Schwarz J; Gratz S; Kaiser JW; Jarnig M; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S15-8. PubMed ID: 18437637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease.
    Mahlknecht P; Hotter A; Hussl A; Esterhammer R; Schocke M; Seppi K
    Neurodegener Dis; 2010; 7(5):300-18. PubMed ID: 20616565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Magnetic resonance tomography in patients with Parkinson's disease and Parkinson-plus syndromes].
    Hierholzer J; Schrag A; Cordes M; Sander B; Schelosky L; Harisch C; Venz S; Keske U; Mäurer J; Poewe W; Felix R
    Rofo; 1996 Jul; 165(1):43-51. PubMed ID: 8765362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
    Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
    Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.